Search Results

There are 13288 results for: content related to: Results of a randomized, double-blind study of romiplostim versus placebo in patients with low/intermediate-1–risk myelodysplastic syndrome and thrombocytopenia

  1. You have free access to this content
    Thrombopoiesis-stimulating agents and myelodysplastic syndromes

    British Journal of Haematology

    Volume 169, Issue 3, May 2015, Pages: 309–323, Charlotte K. Brierley and David P. Steensma

    Version of Record online : 6 FEB 2015, DOI: 10.1111/bjh.13285

  2. Long-term safety and tolerability of romiplostim in patients with primary immune thrombocytopenia: a pooled analysis of 13 clinical trials

    European Journal of Haematology

    Volume 91, Issue 5, November 2013, Pages: 423–436, Francesco Rodeghiero, Roberto Stasi, Aristoteles Giagounidis, Jean-François Viallard, Bertrand Godeau, Ingrid Pabinger, Douglas Cines, Howard Liebman, Xuena Wang and Paul Woodard

    Version of Record online : 17 SEP 2013, DOI: 10.1111/ejh.12181

  3. Thrombopoietin mimetics for patients with myelodysplastic syndromes

    Intervention Review

    The Cochrane Library

    Helga Dodillet, Karl-Anton Kreuzer, Ina Monsef and Nicole Skoetz

    Published Online : 30 SEP 2017, DOI: 10.1002/14651858.CD009883.pub2

  4. Romiplostim Dose Response in Patients With Immune Thrombocytopenia

    The Journal of Clinical Pharmacology

    Volume 52, Issue 10, October 2012, Pages: 1540–1551, Dr J. J. Perez-Ruixo, Dr B. Green, Dr S. Doshi, Dr Y.-M. Wang and Dr D. R. Mould

    Version of Record online : 7 MAR 2013, DOI: 10.1177/0091270011420843

  5. You have full text access to this OnlineOpen article
    A large observational study of patients with primary immune thrombocytopenia receiving romiplostim in European clinical practice

    European Journal of Haematology

    Volume 98, Issue 2, February 2017, Pages: 112–120, Michael Steurer, Philippe Quittet, Helen A. Papadaki, Dominik Selleslag, Jean-François Viallard, Georgia Kaiafa, Ann Janssens, Tomas Kozak, Hans Wadenvik, Marieke Schoonen, Laura Belton and Georg Kreuzbauer

    Version of Record online : 26 SEP 2016, DOI: 10.1111/ejh.12807

  6. You have free access to this content
    Evaluation of bleeding and thrombotic events during long-term use of romiplostim in patients with chronic immune thrombocytopenia (ITP)

    Journal of Thrombosis and Haemostasis

    Volume 8, Issue 6, June 2010, Pages: 1372–1382, T. B. GERNSHEIMER, J. N. GEORGE, L. M. ALEDORT, M. D. TARANTINO, U. SUNKARA, D. MATTHEW GUO and J. L. NICHOL

    Version of Record online : 3 MAR 2010, DOI: 10.1111/j.1538-7836.2010.03830.x

  7. You have free access to this content
    Use of eltrombopag after romiplostim in primary immune thrombocytopenia

    British Journal of Haematology

    Volume 169, Issue 1, April 2015, Pages: 111–116, José Ramón González-Porras, María Eva Mingot-Castellano, Marcio M. Andrade, Rafael Alonso, Isabel Caparrós, María Carmen Arratibel, Fernando Fernández-Fuertes, Maria José Cortti, Cristina Pascual, Blanca Sánchez-González, Silvia Bernat, Miguel Angel Fuertes-Palacio, Juan Andrés Vázquez-Paganini, Pavel E. Olivera, María Teresa Alvarez-Román, Isidro Jarque, Montserrat Cortés, Violeta Martínez-Robles, Francisco Javier Díaz-Gálvez, María Calbacho, Carmen Fernández-Miñano, Javier Garcia-Frade and Tomás José González-López

    Version of Record online : 18 DEC 2014, DOI: 10.1111/bjh.13266

  8. You have free access to this content
    Alternative agents to prophylactic platelet transfusion for preventing bleeding in people with thrombocytopenia due to chronic bone marrow failure: a meta-analysis and systematic review

    Intervention Review

    The Cochrane Library

    Michael Desborough, Andreas V Hadjinicolaou, Anna Chaimani, Marialena Trivella, Paresh Vyas, Carolyn Doree, Sally Hopewell, Simon J Stanworth and Lise J Estcourt

    Published Online : 31 OCT 2016, DOI: 10.1002/14651858.CD012055.pub2

  9. You have free access to this content
    Health-related quality of life in nonsplenectomized immune thrombocytopenia patients receiving romiplostim or medical standard of care

    American Journal of Hematology

    Volume 87, Issue 5, May 2012, Pages: 558–561, David J. Kuter, Susan D. Mathias, Mathias Rummel, Romeo Mandanas, Aristoteles A. Giagounidis, Xuena Wang and Robert R. Deuson

    Version of Record online : 28 MAR 2012, DOI: 10.1002/ajh.23163

  10. You have free access to this content
    Romiplostim dose–response in patients with myelodysplastic syndromes

    British Journal of Clinical Pharmacology

    Volume 75, Issue 6, June 2013, Pages: 1445–1454, Juan Jose Perez Ruixo, Sameer Doshi, Yow-Ming C. Wang and Diane R. Mould

    Version of Record online : 20 MAY 2013, DOI: 10.1111/bcp.12041

  11. You have free access to this content
    Long-term treatment with romiplostim in patients with chronic immune thrombocytopenia: safety and efficacy

    British Journal of Haematology

    Volume 161, Issue 3, May 2013, Pages: 411–423, David J. Kuter, James B. Bussel, Adrian Newland, Ross I. Baker, Roger M. Lyons, Jeffrey Wasser, Jean-Francois Viallard, Gail Macik, Mathias Rummel, Kun Nie and Susie Jun

    Version of Record online : 22 FEB 2013, DOI: 10.1111/bjh.12260

  12. TPO receptor agonist for chronic idiopathic thrombocytopenic purpura

    Intervention Review

    The Cochrane Library

    Yan Zeng, Xin Duan, Jiajun Xu and Xun Ni

    Published Online : 6 JUL 2011, DOI: 10.1002/14651858.CD008235.pub2

  13. You have free access to this content
    Remission and platelet responses with romiplostim in primary immune thrombocytopenia: final results from a phase 2 study

    British Journal of Haematology

    Volume 172, Issue 2, January 2016, Pages: 262–273, Adrian Newland, Bertrand Godeau, Victor Priego, Jean-Francois Viallard, María F. López Fernández, Amelia Orejudos and Melissa Eisen

    Version of Record online : 5 NOV 2015, DOI: 10.1111/bjh.13827

  14. You have full text access to this OnlineOpen article
    Romiplostim monotherapy in thrombocytopenic patients with myelodysplastic syndromes: long-term safety and efficacy

    British Journal of Haematology

    Volume 178, Issue 6, September 2017, Pages: 906–913, Pierre Fenaux, Petra Muus, Hagop Kantarjian, Roger M. Lyons, Richard A. Larson, Mikkael A. Sekeres, Pamela S. Becker, Amelia Orejudos and Janet Franklin

    Version of Record online : 14 JUN 2017, DOI: 10.1111/bjh.14792

  15. Effect of a thrombopoietin receptor agonist on use of intravenous immune globulin in patients with immune thrombocytopenia

    Transfusion

    Volume 56, Issue 1, January 2016, Pages: 73–79, Michelle P. Zeller, Nancy M. Heddle, John G. Kelton, Korinne Hamilton, Grace Wang, Naushin Sholapur, Julie Carruthers, Cyrus Hsia, Normand Blais, Lisa Toltl, Caroline Hamm, Marc-André Pearson and Donald M. Arnold

    Version of Record online : 24 SEP 2015, DOI: 10.1111/trf.13336

  16. Thrombopoietin receptor agonists for prevention and treatment of chemotherapy-induced thrombocytopenia in patients with solid tumours

    Intervention Review

    The Cochrane Library

    Xia Zhang, Yunhai Chuai, Wei Nie, Aiming Wang and Guanghai Dai

    Published Online : 27 NOV 2017, DOI: 10.1002/14651858.CD012035.pub2

  17. Romiplostim in the management of the thrombocytopenic surgical patient

    Transfusion

    Volume 55, Issue 10, October 2015, Pages: 2505–2510, Ariela L. Marshall, Katayoon Goodarzi and David J. Kuter

    Version of Record online : 30 MAY 2015, DOI: 10.1111/trf.13181

  18. The treatment for primary immune thrombocytopenia with romiplostim in adult and paediatric patients: use experience at a Spanish university hospital

    Journal of Clinical Pharmacy and Therapeutics

    Volume 39, Issue 4, August 2014, Pages: 376–382, I. Marquínez-Alonso, V. Escudero-Vilaplana, S. Pernía, C. Beléndez Bieler, C. M. Fernández-Llamazares and M. Sanjurjo-Sáez

    Version of Record online : 4 APR 2014, DOI: 10.1111/jcpt.12156

  19. Impact of self-administration of romiplostim by patients with chronic immune thrombocytopenia compared with administration by a healthcare provider

    European Journal of Haematology

    Volume 94, Issue 2, February 2015, Pages: 169–176, Dominik Selleslag, Robert Bird, Ivy Altomare, Aristoteles Giagounidis, Ann Janssens, Ingrid Pabinger, Vinod Pullarkat, Helen Wei and Georg Kreuzbauer

    Version of Record online : 8 AUG 2014, DOI: 10.1111/ejh.12415

  20. You have free access to this content
    Romiplostim: a breakthrough treatment for the management of immune thrombocytopenic purpura

    European Journal of Haematology

    Volume 82, Issue s71, March 2009, Pages: 20–25, Adrian Newland

    Version of Record online : 6 FEB 2009, DOI: 10.1111/j.1600-0609.2008.01209.x